Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2-Aminopyridine | HCID 10439 | — |
| Reactant | Sodium borohydride | HCID 4311764 | — |
| Reactant | HCID 59333301 | HCID 59333301 | — |
| Catalyst | Titanium isopropoxide | HCID 11026 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 25120171 | HCID 25120171 | 25.7% |
Reaction Steps
To a solution of 4-[(3-hydroxypropyl)amino]-7-(trifluoromethyl)imidazo[1,2-a]quinoxaline-8-carbaldehyde (25 mg; 0.07 mmol; 1 eq), 2-aminopyridine (20 mg; 0.21 mmol; 3 eq) and titanium tetraisopropoxide (60 mg; 0.21 mg; 3 eq) in anhydrous tetrahydrofuran (0.2 ml) with a few 4A molecular sieves stirred under Ar at rt for 5 h is added sodium borohydride (3 mg; 0.07 mmol; 1 eq). The resulting reaction mixture is then stirred under Ar at rt for 16 h. Partition (aqueous ammonium chloride/ethyl acetate), filtration over Celite, extraction of the aqueous phase (ethyl acetate), reunion of the organic phases, drying (magnesium sulphate) and purification by prep CCM on silicagel (dichloromethane/methanol 95:5) affords the title product (7.4 mg; 0.018 mmol; 25%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08513250B2 |
|---|
| Source dataset | uspto-grants-2013_08 |
|---|
| ORD ID | ord-cda8a5d5aba440f8af45ceae4d84a3e0 |
|---|
| Source note | uspto-grants-2013_08 |
|---|